文献速递胸部技术与安全CT

COVID-19肺炎中CT使用、扫描方案与辐射剂量的差异:国际原子能机构28国研究结果

Variations in CT Utilization, Protocols, and Radiation Doses in COVID-19 Pneumonia: Results from 28 Countries in the IAEA Study.
PubMed 文献 · Radiology · 2020-11-10

该回顾性数据采集研究由国际原子能机构协调,于2020年5月至7月调查28国54个医疗站点782例COVID-19肺炎患者的CT使用、扫描方案与辐射剂量。结果显示各站点CT使用指征、扫描方案及辐射剂量差异广泛,部分患者多次成像或采用多期扫描方案。

要点

  • 各医疗站点CT使用指征、扫描方案及辐射剂量差异广泛。
  • CT剂量指数随CT厂商、探测器排数、安装年份及重建技术不同而变化。
  • 20%站点采用多期胸部CT,其剂量长度乘积高于80%站点的单期胸部CT。

核心结论

  • COVID-19肺炎患者的CT使用、扫描方案及辐射剂量在同一国家内不同站点及不同国家间均呈现广泛差异。
  • 许多患者被多次成像和/或采用多期CT扫描方案。

研究设计与样本

  • 回顾性数据采集研究,国际原子能机构协调于2020年5月至7月开展问卷调查,覆盖五大洲34国62个医疗站点。
  • 最终分析28国54个医疗站点782例患者(中位年龄59岁,四分位距15岁)。
  • 问卷获取当地患病率、诊断方法、最常见成像、CT指征及COVID-19肺炎CT使用具体政策。
  • 采集数据包括患者一般信息、CT设备信息、扫描方案及辐射剂量描述符;采用描述性统计和广义估计方程分析。

诊断标准与关键数值

  • CT剂量指数随CT厂商不同为7-11 mGy(P < .001)。
  • CT剂量指数随探测器排数不同为8-9 mGy(P < .001)。
  • CT剂量指数随CT安装年份不同为7-10 mGy(P = .006)。
  • CT剂量指数随重建技术不同为7-10 mGy(P = .03)。
  • 20%站点(11/54)行多期胸部CT,其剂量长度乘积高于80%站点(43/54)行单期胸部CT(P = .008)。

临床应用与阅片要点

  • 不足半数站点将CT用于COVID-19肺炎的初始诊断。
  • 四分之三站点将CT用于评估疾病严重程度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background There is lack of guidance on specific CT protocols for imaging patients with coronavirus disease 2019 (COVID-19) pneumonia. Purpose To assess international variations in CT utilization, protocols, and radiation doses in patients with COVID-19 pneumonia. Materials and Methods In this retrospective data collection study, the International Atomic Energy Agency coordinated a survey between May and July 2020 regarding CT utilization, protocols, and radiation doses from 62 health care sites in 34 countries across five continents for CT examinations performed in patients with COVID-19 pneumonia. The questionnaire obtained information on local prevalence, method of diagnosis, most frequent imaging, indications for CT, and specific policies on use of CT in COVID-19 pneumonia. Collected data included general information (patient age, weight, clinical indication), CT equipment (CT make and model, year of installation, number of detector rows), scan protocols (body region, scan phases, tube current and potential), and radiation dose descriptors (CT dose index and dose length product). Descriptive statistics and generalized estimating equations were performed. Results Data from 782 patients (median age, 59 years [interquartile range, 15 years]) from 54 health care sites in 28 countries were evaluated. Less than one-half of the health care sites used CT for initial diagnosis of COVID-19 pneumonia and three-fourths used CT for assessing disease severity. CT dose index varied based on CT vendors (7-11 mGy; P < .001), number of detector rows (8-9 mGy; P < .001), year of CT installation (7-10 mGy; P = .006), and reconstruction techniques (7-10 mGy; P = .03). Multiphase chest CT examinations performed at 20% of sites (11 of 54) were associated with higher dose length product compared with single-phase chest CT examinations performed in 80% of sites (43 of 54) (P = .008). Conclusion CT use, scan protocols, and radiation doses in patients with coronavirus disease 2019 pneumonia showed wide variation across health care sites within the same and between different countries. Many patients were imaged multiple times and/or with multiphase CT scan protocols. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Lee in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Homayounieh F, Holmberg O, Umairi RA, et al. Variations in CT Utilization, Protocols, and Radiation Doses in COVID-19 Pneumonia: Results from 28 Countries in the IAEA Study. Radiology. 2020. PMID: 33170104. doi:10.1148/radiol.2020203453

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。